ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0168

Semiquantitative Thigh Magnetic Resonance Imaging (tMRI) in Determining Skeletal Muscle Outcomes at Baseline and on Follow up in Idiopathic Inflammatory Myopathies (IIMs)

Mamatha Gorijavolu1, Devender Bairwa2, Chengappa Kavadichanda3, Sai Kumar Dunga4, Aishwarya Gopal5, Vir Singh Negi6 and Molly Thabah1, 1Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, Puducherry, India, 2Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, Puducherry, India, 3JIPMER, Pondicherry, Puducherry, India, 4Jawaharlal institute of postgraduate medical education and research, Srikakulam, India, 5Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, Puducherry, India, 6AIIMS Bilaspur, Puducherry, Puducherry, India

Meeting: ACR Convergence 2022

Keywords: Magnetic resonance imaging (MRI), Myositis, Outcome measures

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 12, 2022

Title: Muscle Biology, Myositis and Myopathies Poster I

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: Semiquantitative scoring of thigh Magnetic Resonance Imaging (tMRI) has shown contradictory results in associating muscle inflammation, damage, and clinically assessed muscle weakness. Moreover, there are no studies assessing the role of tMRI detected muscle damage in determining long-term recovery of muscle strength and endurance.

Objectives: To correlate tMRI scores with concurrently collected manual muscle testing 8 (MMT-8) scores, Two-minute walking Distance(2-MWD) and muscle enzymes. To evaluate the role of baseline tMRI scores in predicting maximum muscle power and 2MWD during follow up.

Methods: This is a retrospective analysis of a single-centre myositis cohort. IIM patients (n=59) who underwent tMRI (STIR and T1 axial and coronal sequences) at the time of diagnosis were included. Baseline demographic, clinical, and serological parameters were noted. MRI images were assessed for intramuscular and fascial edema, muscle atrophy and fatty replacement using a semiquantitative score and the percentage of muscle involvement for each parameter was calculated. On follow up the maximum MMT-8 and 2-MWD for each patient was determined if the two values remained unchanged on 2 separate evaluations at least 3 months apart (n=38). Spearman correlation was done between clinical parameters, muscle enzymes, and tMRI scores. Baseline parameters of patients who achieved and did not achieve maximum MMT8≥74 were compared. Multiple linear regression was performed to assess the tMRI variables predicting MMT-8 and 2-MWD during follow-up.

Results: The median age of the cohort (figure 1) was 38 (30-47) years with a median duration of disease of 4 months (2-12). The Median follow up of the 38 individuals was 31 months (10.00-57.00). Baseline MMT-8 showed strong negative correlation with muscle edema on tMRI (r=-0.755), moderate negative correlation with fascial edema(r=-0.443) and muscle atrophy(r=-0.343). Baseline 2-MWD showed a moderate negative correlation with muscle edema (r=-0.575). Baseline muscle enzymes creatinine kinase (CPK) (r=0.422) and Aspartate transaminase (AST) (r=0.480) showed a moderate positive correlation with tMRI scores for muscle edema. Lactate Dehydrogenase (LDH) (r=0.237) did not significantly correlate with muscle edema. Maximum MMT-8 showed moderate negative correlation with muscle atrophy (r=-0.497) and fatty infiltration(r=-0.531) (Figure2). Follow up 2-MWD showed moderate negative correlation with muscle atrophy(r=-0.353) and fatty infiltration(r=-0.482). Muscle atrophy and fatty infiltration were significantly different between patients who achieved and did not achieve MMT-8 of ≥74 on follow-up (Table 1). Multiple linear regression analysis revealed an adjusted R2 value of 0.655. Muscle atrophy (β=-0.552) and Fatty infiltration (β=-0.418) on baseline tMRI significantly predicted MMT-8 on follow-up independent of other variables.

Conclusion: Muscle loss at baseline in the form of fatty infiltration and atrophy portends poor recovery of muscle power independent of autoantibody status, age and duration.

Supporting image 1

Figure 1: Distribution of IIM subtypes in the cohort

Supporting image 2

Figure 2: Correlation of baseline and Follow up MMT-8 with tMRI scores

Supporting image 3

Table 1: Comparison between those who achieved near-normal muscle power versus others


Disclosures: M. Gorijavolu, None; D. Bairwa, None; C. Kavadichanda, None; S. Dunga, None; A. Gopal, None; V. Negi, None; M. Thabah, None.

To cite this abstract in AMA style:

Gorijavolu M, Bairwa D, Kavadichanda C, Dunga S, Gopal A, Negi V, Thabah M. Semiquantitative Thigh Magnetic Resonance Imaging (tMRI) in Determining Skeletal Muscle Outcomes at Baseline and on Follow up in Idiopathic Inflammatory Myopathies (IIMs) [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/semiquantitative-thigh-magnetic-resonance-imaging-tmri-in-determining-skeletal-muscle-outcomes-at-baseline-and-on-follow-up-in-idiopathic-inflammatory-myopathies-iims/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/semiquantitative-thigh-magnetic-resonance-imaging-tmri-in-determining-skeletal-muscle-outcomes-at-baseline-and-on-follow-up-in-idiopathic-inflammatory-myopathies-iims/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology